Scientific analysis of Restylane® Defyne™: mechanism, evidence and distinguishing features of hyaluronic acid with Optimal Balance Technology™ for deep folds.
Introduction
Restylane® Defyne™ is a hyaluronic acid (HA)–based dermal filler formulated to soften deep folds and wrinkles, restore facial volume and preserve natural expression. Developed with Optimal Balance Technology™ (OBT) and 0.3% lidocaine, Defyne combines structural support and flexibility for natural, long-lasting results. In this scientific yet accessible article, we review the mechanism of action, clinical indications, evidence, product differentiators and practical considerations for clinicians.
Mechanism of Action
Restylane® Defyne™ is composed of hyaluronic acid cross-linked with BDDE, forming a cohesive gel with specific viscoelastic properties. Cross-linking increases HA durability by slowing its enzymatic degradation by endogenous hyaluronidase, while the matrix obtained by OBT promotes a balance between elasticity (G') and cohesion, allowing support without loss of facial mobility (Papakonstantinou et al., 2012). HA attracts and retains water, providing immediate tissue hydration and gradual volumization.
Optimal Balance Technology™ (OBT)
OBT is a formulation approach that combines gel particles with different degrees of cross-linking to obtain a product able to support mechanical loads (e.g., mastication, smiling) without becoming stiff. This allows Defyne to fill deep folds such as nasolabial folds and marionette lines while preserving natural facial movements (Sundaram & Voigt, 2014).
Clinical Indications
- Correction of moderate to deep nasolabial folds.
- Correction of marionette and labial commissure-to-chin lines.
- Deep dynamic wrinkles in areas of high facial expression.
- Restoration of focal volume in areas requiring a combination of support and flexibility.
The product is indicated for use in adults and should be administered by physicians trained in dermal filler techniques.
Scientific Evidence
Clinical studies on HA-based fillers demonstrate efficacy in reducing folds and an acceptable safety profile when administered by experienced professionals. Reviews on HA describe its capacity to retain water, modulate the extracellular matrix and provide temporary aesthetic improvement with a known safety profile (Papakonstantinou et al., 2012).
Comparative trials and clinical evaluations specific to HA technologies with distinct viscoelastic properties have shown that formulations balancing elasticity and cohesion result in effective correction of deep folds while preserving facial expression (Narins et al., 2009; Sundaram & Voigt, 2014). In published clinical series, fillers with a profile similar to Defyne have shown a mean duration of 6 to 12 months for nasolabial fold correction, variable according to patient age, metabolism and lifestyle.
Benefits and Differentiators of Restylane Defyne
- Flexibility with support: OBT enables natural results in dynamic areas, reducing the risk of an artificial appearance.
- Comfort: Contains 0.3% lidocaine to reduce procedural pain.
- Durability: Typical results between 6 and 12 months, with the option for maintenance touch-ups.
- Predictable tissue integration: Cohesive gel that minimizes migration and facilitates immediate molding.
- Known safety profile: HA is biocompatible and reversible with hyaluronidase in case of complications.
Considerations for Clinicians
Before the procedure, a comprehensive medical assessment is essential, including allergy history, anticoagulant use, pregnancy or lactation, local infections and patient expectations. Injection techniques (midline versus supraperiosteal, use of cannula vs needles) should be chosen according to topography, defect depth and structural support requirements.
Planning and Technique
- Mark reference points with the patient in an upright position.
- Use strict aseptic technique and, if indicated, additional topical anesthesia despite the lidocaine present.
- Inject at the appropriate plane (superficial to mid-dermal for folds; supraperiosteal for structural support) with incremental volumes and dynamic assessment.
Adverse Event Management
Transient reactions include edema, erythema and bruising, typical in the first 3–7 days. Nodules and irregularities are uncommon; they often respond to massage, intralesional corticosteroid injection or hyaluronidase to dissolve the gel. In case of ischemic signs (severe pain, pallor, livedo), stop injection, apply massage, local heat, vasodilation and administer hyaluronidase according to emergency protocol (Lemperle et al., 2006).
Conclusion and Call to Action
Restylane® Defyne™ is a scientifically supported option for correction of deep wrinkles and nasolabial folds when the goal is to obtain support without losing facial expressivity. Its formulation with OBT and lidocaine provides a balance between naturalness, comfort and durability. Qualified professionals should individualize technique, assess risks and counsel patients about realistic expectations.
To purchase original Restylane® Defyne™ with guaranteed provenance and fast shipping, visit Acquafiller. Buy now at Acquafiller and receive your product with secure shipping via FedEx Express.
Scientific References
- Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: A key molecule in skin ageing. Dermatoendocrinol. 2012;4(3):253-258. doi:10.4161/derm.21923
- Narins RS, Brandt F, Leyden J, et al. Multicenter, randomized, evaluator-blinded study of hyaluronic acid fillers for correction of nasolabial folds. Dermatol Surg. 2009;35(8):1205-1219.
- Sundaram H, Voigt D. The role of rheology in soft tissue augmentation: physical and clinical implications. Plast Reconstr Surg. 2014;134(4 Suppl):39S-49S.
- Lemperle G, Rullan PP, Gauthier-Hazan N. Avoidance and treatment of complications from injectable fillers. Aesthet Surg J. 2006;26(6):8-33.
Comments
Post a Comment